相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome
Lisa J. Moran et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Anti-Mullerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome
Nicolas Crisosto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome
Mei-Jou Chen et al.
HYPERTENSION (2007)
Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology
Aykut Bayrak et al.
FERTILITY AND STERILITY (2007)
Association of anti-mullerian hormone levels with obesity in late reproductive-age women
Ellen W. Freeman et al.
FERTILITY AND STERILITY (2007)
Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation
Wouter J. K. Hehenkamp et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS
Mei-Jou Chen et al.
HUMAN REPRODUCTION (2006)
Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro
I. B. Carlsson et al.
HUMAN REPRODUCTION (2006)
Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus
Ethel Codner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome
P Pigny et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Anti-Mullerian hormone: a new marker for ovarian function
JA Visser et al.
REPRODUCTION (2006)
Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?
A. La Marca et al.
CLINICAL ENDOCRINOLOGY (2006)
The relationship between obesity and race on inhibin B during the menopause transition
CR Gracia et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2005)
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters
E Carmina et al.
FERTILITY AND STERILITY (2005)
Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome
T Piltonen et al.
HUMAN REPRODUCTION (2005)
Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype
RS Legro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Anti-Mullerian hormone and folliculogenesis
JA Visser et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2005)
Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study
IAJ van Rooij et al.
FERTILITY AND STERILITY (2005)
High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status
R Fanchin et al.
HUMAN REPRODUCTION (2005)
Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment
R Fleming et al.
FERTILITY AND STERILITY (2005)
The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest
S Jonard et al.
HUMAN REPRODUCTION UPDATE (2004)
Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment
C Weenen et al.
MOLECULAR HUMAN REPRODUCTION (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
BCJM Fauser et al.
HUMAN REPRODUCTION (2004)
Improving reproductive performance in overweight/obese women with effective weight management
RJ Norman et al.
HUMAN REPRODUCTION UPDATE (2004)
Ultrasound assessment of the polycystic ovary: international consensus definitions
AH Balen et al.
HUMAN REPRODUCTION UPDATE (2003)
Ultrasound examination of polycystic ovaries: is it worth counting the follicles?
S Jonard et al.
HUMAN REPRODUCTION (2003)
Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest
P Pigny et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Antimullerian hormone serum levels: a putative marker for ovarian aging
A de Vet et al.
FERTILITY AND STERILITY (2002)
Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome
C Cortet-Rudelli et al.
FERTILITY AND STERILITY (2002)
Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary
ALL Durlinger et al.
ENDOCRINOLOGY (2002)
Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary
ALL Durlinger et al.
ENDOCRINOLOGY (2001)
Anti-Mullerian hormone and its receptors
N Josso et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Anti-Mullerian hormone is a specific marker of Sertoli- and granulosa-cell origin in gonadal tumors
R Rey et al.
HUMAN PATHOLOGY (2000)
Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism
P Pigny et al.
FERTILITY AND STERILITY (2000)
Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?
TL Loucks et al.
FERTILITY AND STERILITY (2000)
分享论文
